SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
More Information Supplier PageR306465 is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models.
More Information Supplier PageR306465 is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models.
More Information Supplier PageR306465 is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models.
More Information Supplier PageCH-223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.
More Information Supplier PageCH-223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.
More Information Supplier PageCH-223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor.
More Information Supplier PageCyclosporin H is a TPA/PMA inhibitor and a selective inhibitor of formyl peptide receptors (Ki = 0.1 ?M).
More Information Supplier PageCyclosporin H is a TPA/PMA inhibitor and a selective inhibitor of formyl peptide receptors (Ki = 0.1 ?M).
More Information Supplier PageBeta-amyloid protein (A beta), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP), is also the principal component of amyloid.
More Information Supplier Page
